These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 455020)

  • 1. Parkinson's disease.
    Mace M; Rawlins MD
    Br Med J; 1979 May; 1(6173):1266. PubMed ID: 455020
    [No Abstract]   [Full Text] [Related]  

  • 2. A controlled study comparing trihexyphenidyl hydrochloride plus levodopa with placebo plus levodopa in patients with Parkinson's disease.
    Martin WE; Loewenson RB; Resch JA; Baker AB
    Neurology; 1974 Oct; 24(10):912-9. PubMed ID: 4606107
    [No Abstract]   [Full Text] [Related]  

  • 3. 3-O-Methyldopa in Parkinson's disease.
    Muenter MD; Sharpless NS; Tyce GM
    Adv Neurol; 1974; 5():309-15. PubMed ID: 4440579
    [No Abstract]   [Full Text] [Related]  

  • 4. Parkinson's disease improvement after the addition of levodopa-carbidopa to anticholinergic treatment. An open controlled study.
    Agnoli A; Ruggieri S; Denaro A; Lelli A
    Acta Neurol (Napoli); 1978 Oct; 33(5):436-42. PubMed ID: 756675
    [No Abstract]   [Full Text] [Related]  

  • 5. How to achieve maximum benefit for the patient with Parkinson's disease.
    Greer M
    Geriatrics; 1976 Apr; 31(4):89-96. PubMed ID: 4356
    [No Abstract]   [Full Text] [Related]  

  • 6. Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with Parkinson's disease.
    Hauser RA; Olanow CW
    Mov Disord; 1993 Oct; 8(4):512-4. PubMed ID: 8232363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease.
    Taylor J
    Aust Nurses J; 1977 Nov; 7(5):27. PubMed ID: 245293
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combined treatment of parkinsonism with L-dopa and Parkopan].
    Lukasiewicz K
    Wiad Lek; 1977 May; 30(10):775-7. PubMed ID: 867994
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.
    Parkes JD; Baxter RC; Marsden CD; Rees JE
    J Neurol Neurosurg Psychiatry; 1974 Apr; 37(4):422-6. PubMed ID: 4838913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug management of Parkinson's disease.
    Kishore A; Snow BJ
    Can Fam Physician; 1996 May; 42():946-52. PubMed ID: 8688697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined therapy of carbidopa and levodopa in Parkinson's disease].
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):201-4. PubMed ID: 4075908
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of L-dopa holiday in the long-term management of Parkinson's disease.
    Kaye JA; Feldman RG
    Clin Neuropharmacol; 1986; 9(1):1-13. PubMed ID: 3548951
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neurological aspects and modern trends in therapy of Parkinson's disease].
    Pavoncello S; Di Bianco V; Di Castro A; Caviglia A; Cellitti M
    Clin Ter; 1980 Feb; 92(4):433-8. PubMed ID: 7449321
    [No Abstract]   [Full Text] [Related]  

  • 14. Sinemet in Parkinson's disease: efficacy with and without food.
    Bozek CB; Suchowersky O; Purves S; Calne S; Calne DB
    Clin Neuropharmacol; 1986; 9(2):196-9. PubMed ID: 3708604
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom.
    Lees AJ
    BMJ; 1995 Dec; 311(7020):1602-7. PubMed ID: 8555803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nighttime levodopa infusions to treat motor fluctuations in advanced Parkinson's disease: preliminary observations.
    Sage JI; Mark MH
    Ann Neurol; 1991 Oct; 30(4):616-7. PubMed ID: 1789688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy of extrapyramidal disease with trihexyphenidyl and L-dopa: an electromyographic study with specific reference to tremor.
    Hökendorf H
    J Int Med Res; 1979; 7(1):19-28. PubMed ID: 421963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of selegiline in the early and late phases of Parkinson's disease.
    Csanda E; Tárczy M
    Adv Neurol; 1993; 60():672-5. PubMed ID: 8420208
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson's disease: focus on levodopa/carbidopa/entacapone.
    Reichmann H; Emre M
    Expert Rev Neurother; 2012 Feb; 12(2):119-31. PubMed ID: 22288667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Parkinson's disease with carbidopa, a peripheral decarboxylase inhibitor, and levodopa.
    Fermaglich J
    Med Ann Dist Columbia; 1974 Dec; 43(12):587-91. PubMed ID: 4532167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.